Back to search results

MyoMo for Upper Extremity Function in Spinal Cord Injury

This study is looking at how well an assistive device called MyoMo (also known as MyoPro) helps people with spinal cord injury (SCI) improve their arm and hand function. It compares using the MyoMo device to conventional therapy. The goal is to see if MyoMo can improve daily activities and quality of life for individuals with incomplete spinal cord injury affecting their arms and hands. You might be able to join if you are between 18 and 80 years old, have a C1-C8 spinal cord injury (ASIA Impairment Scale C or D), and can activate certain arm muscles on your own. The study will measure improvements in hand and arm range of motion, muscle strength, and overall function (GRASSP score) after about 36 weeks. The study status is currently unclear, and it plans to enroll 60 participants.

Study design
This is an interventional study planning to enroll 60 participants. It compares the MyoMo device to conventional therapy.
What's involved
Not specified in the trial record.
Compensation
Not stated in the trial record.
Follow-up
Participants will be followed for approximately 36 weeks to measure outcomes.

AI-generated from the public study record. Only the study team can confirm whether you're eligible — confirm details with them before making decisions.

NCT06349434

The Utilization Effects of Powered Wearable Orthotics in Improving Upper Extremity Function and ADL in Persons With SCI

Recruiting
NAAges 18–80InterventionalTreatment
Kessler Foundation
~60 participants
Updated 2025-11-24 on ClinicalTrials.gov
What's tested:MyoMoconventional therapy

At a glance

Recruiting sites
1 of 1 listed site is recruiting right now
RecruitingSuspended, closed, or not yet open
What they're measuring
GRASSP
Measured over Approximately 36 weeks
+2 more outcomes measured

Conditions

SCI - Spinal Cord Injury
Upper Extremity Dysfunction
Upper Extremity Problem

Explore related trials

Spinal Cord InjuryUpper Extremity Dysfunction

Where it's being run

1 sites across 1 states
New Jersey1

Who to contact

Ghaith J Androwis, Ph.D.
[email protected]
201-968-6110
Email the study team

Opens a ready-to-send draft in your own email app — review before sending.

Do you actually qualify for this trial?

Add a private profile and we'll compare every criterion below against your situation — and tell you which ones are met, uncertain, or excluding.

Check eligibility for this trial ~2 min · HIPAA-protected · delete anytime
Eligibility criteria

Inclusion

Be between ages 18-80
Be able to activate certain muscles in my arm and forearm on my own a sufficient amount as measured by EMG amplitude. This will be determined by the study OT/PT.
Be diagnosed with spinal cord injury (SCI) with level C1-C8 and ASIA Impairment Scale (AIS) C or D, as determined by study staff. If I have not had an exam to determine my injury level and impairment scale recently, I may participate in an examination of my sensation and strength in my arms, legs, trunk and rectum as was done in the hospital soon after my injury.
Be at least 1-year post injury
Have sufficient ability to move my shoulder (active shoulder flexion of 30 degrees and active shoulder abduction 20 degrees), as determined by study staff
Be medically stable
Have sufficient learning and memory abilities and abilities to communicate in English to be able to participate and follow directions during my rehabilitation
Continue to take all prescribed medication (e.g., oral or via pump baclofen) without any dosing changes
Be able to tolerate functional tasks for 60 minutes with periodic rests without excessive fatigue
Have minimal strength in the muscles that bend and straighten my elbow, as determined by study staff
Have full range of motion in my elbow when it is moved by the study therapist

Exclusion

Be younger than 18 years old or older than 80
Have excessive pain in my arm, wrist, or hand that limits providing rehabilitation
Have excessive spasticity in my elbow or wrist, as determined by study staff
Be participating in any experimental rehabilitation or drug studies
Have history of nervous system disorder other than SCI
Have difficulty following multiple step directions
Have severe cognitive or psychiatric problems might be contraindications to start training.
Have skin issues or severe sensory deficits that would prevent wearing the Myo-Pro device safely
Be pregnant
Have other conditions or circumstances that, in the opinion of the investigators, would affect the safety or effectiveness of the training in which I would participate

What this trial measures

  • GRASSPApproximately 36 weeks

    Assessment of the Hand in Tetraplegia Using the Graded Redefined Assessment of Strength Sensibility and Prehension Upper Extremity (UE) Function in Persons with Tetraplegia Relationships Between Strength, Capacity and the Spinal Cord Independence Measure. Total score's minimum and maximum values are between 0 to 116 and higher scores indicate better/improved outcomes.

  • Range of motion of hands and armsApproximately 36 weeks

    Movement of upper extremity is measured using small sensors that are able to record joints' angles. These sensors are placed on participant's skin via double sticky tape. Participants will be asked to move their hand and forearm while the elbow, wrist and hand joint angles are measured.

  • Muscle strength measurementApproximately 36 weeks

    during movements of upper extremities muscle strength is measured using small and light weight surface electromyography sensors which are placed on the participant's skin via double stick tape. Participants will be asked to move their hand and forearm while the muscle strength is measured.